{"version":"1.0","provider_name":"Market Newsdesk","provider_url":"https:\/\/www.marketnewsdesk.com","author_name":"Newsdesk","author_url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/","title":"Bioasis Announces Annual General Meeting Results - Market Newsdesk","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"O1QQnalP2W\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/\">Bioasis Announces Annual General Meeting Results<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.marketnewsdesk.com\/index.php\/bioasis-announces-annual-general-meeting-results\/embed\/#?secret=O1QQnalP2W\" width=\"600\" height=\"338\" title=\"&#8220;Bioasis Announces Annual General Meeting Results&#8221; &#8212; Market Newsdesk\" data-secret=\"O1QQnalP2W\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.marketnewsdesk.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"GUILFORD, Conn., Dec. 10, 2020 (GLOBE NEWSWIRE) &#8212; BIOASIS TECHNOLOGIES INC\u2013Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the \u201cCompany\u201d or \u201cBioasis\u201d), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3\u2122 platform technology for the delivery of therapeutics across the blood-brain barrier (\u201cBBB\u201d) and the treatment of central nervous system (\u201cCNS\u201d) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (\u201cAGM\u201d) held earlier today in New Haven, Conn., United States. The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board &hellip; Continue reading \"\"","thumbnail_url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEwMDQ2NCMzODY2NjI0IzIxOTkzNTc="}